Early MRD negativity predicts depth of response to CAR T-cells in R/R MM

Nikhil Munshi, MD, of the Dana-Farber Cancer Institute, Boston, MA, presented results from the CRB-401 trial (NCT02658929) at the 23rd Congress of European Hematology Association (EHA) 2018, held in S... Author: VJHemOnc Added: 08/10/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts